Evidence map›Paper›PMID 26633375›Full record

ArticleInternational journal of molecular sciences2015

DAG/PKCδ and IP3/Ca²⁺/CaMK IIβ Operate in Parallel to Each Other in PLCγ1-Driven Cell Proliferation and Migration of Human Gastric Adenocarcinoma Cells, through Akt/mTOR/S6 Pathway.

Lianzhi Dai, Luhua Zhuang, Bingchang Zhang, Fen Wang, Xiaolei Chen, Chun Xia, Bing Zhang

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Reticulocalbin3: A CaCancer science · 2022
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. p21-Activated Kinase 1 Promotes Breast TumorigenesisFrontiers in cell and developmental biology · 2021
    Article
  8. Comprehensive review of targeted therapy for colorectal cancer.Signal transduction and targeted therapy · 2020
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Protein Kinase CJournal of the American Society of Nephrology : JASN · 2017
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Lianzhi DaiMedical School, Xiamen University, Fujian 361102, China. 24520131153431@stu.xmu.edu.cn.
Luhua ZhuangMedical School, Xiamen University, Fujian 361102, China. zhuangluhua@gmail.com.
Bingchang ZhangMedical School, Xiamen University, Fujian 361102, China. bczhang@foxmail.com.
Fen WangMedical School, Xiamen University, Fujian 361102, China. 24520141153450@stu.xmu.edu.cn.
Xiaolei ChenZhongshan Hospital, Xiamen University, Fujian 361004, China. cxl910904@gmail.com.
Chun XiaZhongshan Hospital, Xiamen University, Fujian 361004, China. chunxia@xmu.edu.cn.
Bing ZhangMedical School, Xiamen University, Fujian 361102, China. cristal66@xmu.edu.cn.
Xiamen University · CNZhongshan Hospital of Xiamen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phosphoinositide specific phospholipase Cγ (PLCγ) activates diacylglycerol (DAG)/protein kinase C (PKC) and inositol 1,4,5-trisphosphate (IP3)/Ca(2+)/calmodulin-dependent protein kinase II (CaMK II) axes to regulate import events in some cancer cells, including gastric adenocarcinoma cells. However, whether DAG/PKCδ and IP3/Ca(2+)/CaMK IIβ axes are simultaneously involved in PLCγ1-driven cell proliferation and migration of human gastric adenocarcinoma cells and the underlying mechanism are not elucidated. Here, we investigated the role of DAG/PKCδ or CaMK IIβ in PLCγ1-driven cell proliferation and migration of human gastric adenocarcinoma cells, using the BGC-823 cell line. The results indicated that the inhibition of PKCδ and CaMK IIβ could block cell proliferation and migration of BGC-823 cells as well as the effect of inhibiting PLCγ1, including the decrease of cell viability, the increase of apoptotic index, the down-regulation of matrix metalloproteinase (MMP) 9 expression level, and the decrease of cell migration rate. Both DAG/PKCδ and CaMK IIβ triggered protein kinase B (Akt)/mammalian target of rapamycin (mTOR)/S6 pathway to regulate protein synthesis. The data indicate that DAG/PKCδ and IP3/Ca(2+)/CaMK IIβ operate in parallel to each other in PLCγ1-driven cell proliferation and migration of human gastric adenocarcinoma cells through Akt/mTOR/S6 pathway, with important implication for validating PLCγ1 as a molecular biomarker in early gastric cancer diagnosis and disease surveillance.

Indexed as

Signal TransductionAdenocarcinomaAnimalsApoptosisCalciumCalcium-Calmodulin-Dependent Protein Kinase Type 2Cell Line, TumorCell MovementCell ProliferationDiglyceridesDisease Models, AnimalHeterograftsHumansMicePhospholipase C gammaProtein Kinase C1,2-diacylglycerolCalciumCalcium-Calmodulin-Dependent Protein Kinase Type 2DiglyceridesPhospholipase C gammaProtein Kinase CProto-Oncogene Proteins c-aktRibosomal Protein S6 KinasesTOR Serine-Threonine KinasesAkt/mTOR/S6cell proliferationDAG/PKCδhuman gastric adenocarcinoma cellsIP3/Ca2+/CaMK IIβmigrationPLCγ1

Identifiers

PMID26633375
PMCPMC4691063
OpenAlexW2182436500

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.